The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrated molecular analysis of Asian ovarian cancer: Gene expression and whole exome sequencing analyses from the iPocc Translational Research study (TriPocc).
 
Ruby Huang
Employment - ACT Genomics (I)
Leadership - ACT Genomics (I)
Stock and Other Ownership Interests - ACT Genomics (I)
Consulting or Advisory Role - Roche (I)
 
Tuan Zea Tan
No Relationships to Disclose
 
Jieru Ye
No Relationships to Disclose
 
Christiane Kuschal
No Relationships to Disclose
 
Zuan Yu Mok
No Relationships to Disclose
 
Shane Ee Goh
No Relationships to Disclose
 
Sili Tan
No Relationships to Disclose
 
Jia Xian Tay
No Relationships to Disclose
 
Mohd Feroz Mohd Omar
No Relationships to Disclose
 
Sho Sato
No Relationships to Disclose
 
Anand Devaprasath Jeyasekharan
Honoraria - MSD
Research Funding - AstraZeneca; Janssen
 
Diana Lim
No Relationships to Disclose
 
Richie Chuan Teck Soong
Employment - Inanovate
Stock and Other Ownership Interests - Inanovate
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; MSD
Speakers' Bureau - AstraZeneca; Bayer; Illumina; Perkin Elmer; Thermo Fisher Scientific
Research Funding - Bayer; Bio-Rad; Clearbridge Biomedics; Illumina; Kyowa Hakko Kirin; Roche; Thermo Fisher Scientific
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bio-Rad; Illumina; Inanovate; Perkin Elmer
 
Keiichi Fujiwara
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen Oncology; Kyowa Hakko Kirin; Lilly Japan; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Eisai; MSD; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Kosei Hasegawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Ono Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; MSD
Research Funding - OncoTherapy Science; Pfizer; Yakult Pharmaceutical
 
David Shao Peng Tan
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - AstraZeneca; Karyopharm Therapeutics
Travel, Accommodations, Expenses - AstraZeneca; Merck